Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$363M |
| 2 |
Nike
NKE
|
+$289M |
| 3 |
Home Depot
HD
|
+$271M |
| 4 |
Mastercard
MA
|
+$180M |
| 5 |
Amazon
AMZN
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$226M |
| 2 |
Coca-Cola
KO
|
+$225M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Johnson & Johnson
JNJ
|
+$199M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.84% |
| 2 | Healthcare | 12.18% |
| 3 | Financials | 11.43% |
| 4 | Industrials | 9.05% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
KVH Industries
KVHI
$171M
| $1.6M | ﹤0.01% |
207,300
+23,400
| +13% | +$203K |
|
|
EFC
2327
Ellington Financial
EFC
$1.69B
| $1.59M | ﹤0.01% |
+93,000
| New | +$1.61M |
|
|
YUME
2328
DELISTED
YuMe, Inc.
YUME
| $1.59M | ﹤0.01% |
432,262
+151,962
| +54% | +$565K |
|
2329
Farmers National Banc Corp
FMNB
$945M
| $1.59M | ﹤0.01% |
180,500
+115,300
| +177% | +$1.05M |
|
|
HBP
2330
DELISTED
Huttig Building Products, Inc.
HBP
| $1.59M | ﹤0.01% |
302,415
+199,615
| +194% | +$943K |
|
|
AMRI
2331
DELISTED
Albany Molecular Research Inc
AMRI
| $1.58M | ﹤0.01% |
117,942
-205,300
| -64% | -$2.99M |
|
|
GBL
2332
DELISTED
GAMCO Investors, Inc.
GBL
| $1.58M | ﹤0.01% |
48,300
-21,900
| -31% | -$801K |
|
2333
Grupo SIMEC
SIM
$4.22B
| $1.58M | ﹤0.01% |
210,700
+11,000
| +6% | +$94.9K |
|
|
ELP
2334
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $1.58M | ﹤0.01% |
439,000
+348,000
| +382% | +$1.08M |
|
|
MBRG
2335
DELISTED
Middleburg Financial Corp
MBRG
| $1.57M | ﹤0.01% |
57,800
+16,700
| +41% | +$443K |
|
|
RSO
2336
DELISTED
Resource Capital Corp.
RSO
| $1.57M | ﹤0.01% |
122,100
-413,200
| -77% | -$5.07M |
|
2337
Allient
ALNT
$1.34B
| $1.57M | ﹤0.01% |
101,100
+600
| +0.6% | +$8.52K |
|
2338
RadNet
RDNT
$4.98B
| $1.57M | ﹤0.01% |
293,700
+85,000
| +41% | +$439K |
|
|
APLP
2339
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
| $1.56M | ﹤0.01% |
115,200
-600
| -0.5% | -$7.71K |
|
2340
ORIX
IX
$42.7B
| $1.56M | ﹤0.01% |
+122,000
| New | +$1.7M |
|
|
IBTX
2341
DELISTED
Independent Bank Group, Inc.
IBTX
| $1.56M | ﹤0.01% |
36,300
+4,500
| +14% | +$160K |
|
|
GNBC
2342
DELISTED
Green Bancorp, Inc
GNBC
| $1.55M | ﹤0.01% |
177,900
-29,900
| -14% | -$242K |
|
2343
HCI Group
HCI
$2.34B
| $1.54M | ﹤0.01% |
56,600
+36,300
| +179% | +$1.12M |
|
|
ADAP
2344
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.54M | ﹤0.01% |
189,200
+76,000
| +67% | +$716K |
|
|
PRSS
2345
DELISTED
CafePress Inc.
PRSS
| $1.54M | ﹤0.01% |
497,200
+16,400
| +3% | +$55.7K |
|
|
JNP
2346
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $1.54M | ﹤0.01% |
219,900
+17,000
| +8% | +$120K |
|
2347
Perion Network
PERI
$380M
| $1.54M | ﹤0.01% |
431,367
+65,454
| +18% | +$284K |
|
2348
Revvity
RVTY
$12.6B
| $1.54M | ﹤0.01% |
+29,300
| New | +$1.54M |
|
2349
Hurco Companies Inc
HURC
$132M
| $1.53M | ﹤0.01% |
55,082
-1,000
| -2% | -$31.5K |
|
|
PETX
2350
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.53M | ﹤0.01% |
242,600
+224,200
| +1,218% | +$1.44M |
|
Similar funds
Renaissance Technologies's Q2 2016 Portfolio in Review
As of Q2 2016, Renaissance Technologies held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Renaissance Technologies withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Renaissance Technologies opened a new position in Nike worth $280M.
- Renaissance Technologies's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
- Renaissance Technologies added most to CVS Health in Q2 2016, an estimated $363M increase.
- Renaissance Technologies's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
- Renaissance Technologies fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
- Renaissance Technologies opened 423 new positions and closed 474 in Q2 2016.
- Renaissance Technologies's portfolio value fell 0.13% quarter-over-quarter to $52.5B.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.